Detalles de la búsqueda
1.
A Phase II prospective study of hypofractionated proton therapy of prostate and pelvic lymph nodes: Acute effects on patient-reported quality of life.
Prostate
; 82(14): 1338-1345, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35789497
2.
Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance).
Oncologist
; 2022 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35445723
3.
A clinical calculator to predict disease outcomes in women with triple-negative breast cancer.
Breast Cancer Res Treat
; 185(3): 557-566, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33389409
4.
Baseline Testosterone Levels in Men with Clinically Localized High-Risk Prostate Cancer Treated with Radical Prostatectomy with or without Neoadjuvant Chemohormonal Therapy (Alliance).
J Urol
; 206(2): 319-324, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33780276
5.
Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men.
Prostate
; 80(1): 51-56, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31603253
6.
N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer.
Breast Cancer Res Treat
; 182(3): 613-622, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32504284
7.
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer.
Breast Cancer Res Treat
; 167(1): 89-99, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28913760
8.
Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell Carcinoma.
Int J Mol Sci
; 18(11)2017 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29099775
9.
Common Genetic Variation in CYP17A1 and Response to Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer.
Int J Mol Sci
; 17(7)2016 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27409606
10.
Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer.
NPJ Breast Cancer
; 10(1): 25, 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38553444
11.
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19).
J Clin Oncol
; 42(10): 1114-1123, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38261983
12.
Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: results from North Central Cancer Treatment Group adjuvant trial N9831.
Cancer
; 119(15): 2675-82, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23744760
13.
Late Toxicity of Moderately Hypofractionated Intensity-Modulated Proton Therapy Treating the Prostate and Pelvic Lymph Nodes for High-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 115(5): 1085-1094, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36427645
14.
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial).
J Clin Oncol
; 41(18): 3352-3362, 2023 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36996380
15.
Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials.
Nat Commun
; 14(1): 7053, 2023 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37923752
16.
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer.
Nat Commun
; 14(1): 2215, 2023 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37072398
17.
Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer.
Breast Cancer Res
; 14(3): R75, 2012 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-22577960
18.
Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment.
Mol Cancer Res
; 20(12): 1739-1750, 2022 12 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36135372
19.
Proton Therapy of Prostate and Pelvic Lymph Nodes for High Risk Prostate Cancer: Acute Toxicity.
Int J Part Ther
; 8(2): 41-50, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34722810
20.
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D).
Eur J Cancer
; 148: 287-296, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33765513